China’s CanSino Biologics and a unit of Sinopharm said Wednesday they have applied for public use of their COVID-19 vaccines, and announced efficacy rates.
Seems everybody has a horror story about health insurance: Kafkaesque debates with robotic agents about what is and isn’t covered. Huge bills from a doctor you […]
India plans to expand its vast but faltering coronavirus vaccination programme from March 1 by offering jabs to the over 60s, the government said Wednesday.